Literature DB >> 18066963

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.

J Menzies1, L A Magee, Y C Macnab, J M Ansermino, J Li, M J Douglas, A Gruslin, P Kyle, S K Lee, M P Moore, J M Moutquin, G N Smith, J J Walker, K R Walley, J A Russell, P von Dadelszen.   

Abstract

OBJECTIVE: To determine the association between adverse maternal/perinatal outcomes and Canadian and U.S. preeclampsia severity criteria.
METHODS: Using PIERS data (Preeclampsia Integrated Estimate of RiSk), an international continuous quality improvement project for women hospitalized with preeclampsia, we examined the association between preeclampsia severity criteria and adverse maternal and perinatal outcomes (univariable analysis, Fisher's exact test). Not evaluated were variables performed in <80% of pregnancies (e.g., 24-hour proteinuria).
RESULTS: Few of the evaluated variables were associated with adverse maternal (chest pain/dyspnea, thrombocytopenia, 'elevated liver enzymes', HELLP syndrome, and creatinine >110 microM) or perinatal outcomes (dBP >110 mm Hg and suspected abruption) (at p < 0.01).
CONCLUSIONS: In the PIERS cohort, most factors used in the Canadian or American classifications of severe preeclampsia do not predict adverse maternal and/or perinatal outcomes. Future classification systems should take this into account.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066963     DOI: 10.1080/10641950701521742

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  24 in total

1.  Preeclampsia and the kidney: footprints in the urine.

Authors:  S Ananth Karumanchi; Marshall D Lindheimer
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

2.  Strong ion and weak acid analysis in severe preeclampsia: potential clinical significance.

Authors:  C M Ortner; B Combrinck; S Allie; D Story; R Landau; K Cain; R A Dyer
Journal:  Br J Anaesth       Date:  2015-08       Impact factor: 9.166

3.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

Review 4.  Angiogenic factors in preeclampsia: potential for diagnosis and treatment.

Authors:  Arvind Goel; Sarosh Rana
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

5.  Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model.

Authors:  Shruti Agrawal; Nandita Maitra
Journal:  J Obstet Gynaecol India       Date:  2015-11-11

6.  A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients.

Authors:  Pooja Mathur; Poonam Mathur; Laxmi Maru; Anupama Dave
Journal:  J Obstet Gynaecol India       Date:  2015-11-19

7.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08

Review 8.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.

Authors:  Anne-Marie Côté; Mark A Brown; Elaine Lam; Peter von Dadelszen; Tabassum Firoz; Robert M Liston; Laura A Magee
Journal:  BMJ       Date:  2008-04-10

Review 9.  Pre-eclampsia: an update.

Authors:  Peter von Dadelszen; Laura A Magee
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 10.  Proteinuria as a predictor of complications of pre-eclampsia.

Authors:  G Justus Hofmeyr; Michael Belfort
Journal:  BMC Med       Date:  2009-03-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.